QIA.DE - QIAGEN N.V.

XETRA - XETRA Precio demorado. Divisa en EUR

QIAGEN N.V.

Hulsterweg 82
Venlo 5912 PL
Netherlands
31 77 355 6600
http://www.qiagen.com

SectorHealthcare
SectorDiagnostics & Research
Empleados a tiempo completo5.096

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Thierry BernardCEO & MD1,21MN/A1965
Dr. Roland SackersCFO, MD & Member of Management Board925kN/A1969
Mr. Peer Michael SchatzSr. Advisor7,55MN/A1966
Dr. Barthold PieningSr. VP & Head of Global OperationsN/AN/A1958
Mr. John GilardiVP of Corp. Communications & Investor RelationsN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2019 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc.; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. It serves molecular diagnostics, applied testing, pharma, and academia customers. The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Gobierno corporativo

El ISS Governance QualityScore de QIAGEN N.V., a día 4 de diciembre de 2019, es 4. Las puntuaciones base son Auditoría: 1; Tablero: 1; Derechos de los accionistas: 9; Compensación: 5.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.
Al usar Yahoo aceptas que Yahoo y sus socios puedan utilizar cookies para personalización y otros fines